Search Results
Results found for "Strosberg AD"
- From Failed Experiments to Predictive GPCR Models
One of his early projects involved the A2A adenosine receptor, a GPCR with known relevance in diseases Finally, he advises young scientists to celebrate small wins.
- Innovative Data-Driven Solutions: The pHSense Revolution
Even minor adjustments can compromise photophysical properties. After months of adjustments, a scientist on his team presented a data set that transformed everything Whether in industry or academia, whether overexpressing or not, you can adapt the assay to your system Build or adopt assays that can evolve with your questions—like pHSense.” What’s Next?
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Adaptable Learning Access recorded sessions at your convenience to enhance your understanding. Options 📍 Boston, MA 📅 October 2 -3, 2024 Join leading scientists to investigate the most recent advancements Mexico City 📅 October 23-25, 2024 Engage with your peers and delve into the latest developments in adhesion Unprecedented fragment-based screening using Spectral Shift for GPCRs October 23 - 25, 2024 | 11th Adhesion GPCRs Loss of cardiomyocyte-specific Adhesion G Protein Coupled Receptor G1 (ADGRG1/GPR56) promotes
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
This is the silent advantage of many successful drugs: they bind tightly or covalently , making target For teams advancing candidates, that means identifying kinetic red flags early, not after expensive safety
- Dr. GPCR Updates
This partnership aims to bring advanced chemical probe strategies to the forefront.
- New Tools, Smart Signals, and The Kenakin Brief
On the industry side, Novo Nordisk, Septerna, and Deep Apple advance billion-dollar GPCR programs, while
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Advice for the Next Generation: Don’t Over-Rationalize So what does Eric tell young scientists who want
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Enhancing scientific exploration by concentrating on understanding inhibition to advance GPCR drug discovery Plus: top tracks to watch at GPCR Forum 2025, fresh postdoc openings at the ADME/signaling interface Whether you’re designing a ligand, optimizing ADME, or predicting PK, enzyme inhibition defines what Instead of chasing fragmented feeds, you get a single, credible source that respects your time and advances full of practical knowledge." — DrGPCR University Attendee 🚀 Transform enzyme theory into a discovery advantage
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
difference, discovery teams can anticipate resistance, tune selectivity, and design molecules that adapt Yet many discovery teams still relegate them to the “ADME” checklist, rather than the strategic design
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
Assay sensitivity is like adjusting the brightness on a microscope—set it right, and hidden details jump For GPCR drug discovery, those hidden details can determine whether a compound advances or stalls. From Bench Insight to Strategic Advantage Terry Kenakin’s decades of pharmacology leadership converge on one principle: pipeline advantage begins with sharper experiments . In an era of accelerated GPCR-targeting innovation, these advantages define which programs advance and
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
. 👉 Go behind the scenes with Revvity’s R&D team ➤ Celtarys Research – Advantages of Fluorescent Ligands The Advantages Live-cell imaging: visualize receptor–ligand interactions in real time, without disturbing and real-time signaling shape therapeutic outcomes, fluorescent ligands deliver both precision and adaptability
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
By using two labeled ligands the transference of energy event will only happen when the adequate distance Specific binding is shown, obtained from total binding and unspecific binding (a) CB1R expressing adherent measurement (specific binding measured using CP55490 at 10 μM concentration ) (b) CB 2 R expressing adherent By combining deep expertise in GPCR biology with advanced fluorescence chemistry, Celtarys custom-developed
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
GPCR: A Mission-Aligned Partnership That Advances the Field At Dr.
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
GPCR , the global nonprofit platform dedicated to advancing GPCR science through education, community Developed to address long-standing challenges in GPCR internalization assays , pHSense™ reagents combine Part of a Complete GPCR Reagent Portfolio pHSense™ is the latest addition to Revvity’s GPCR reagent GPCR is a global nonprofit platform advancing GPCR research through education, community, and platform
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
leaders, and pharma innovators who believe that GPCR science is one of the most powerful tools we have to address
- The Five Traps of Ignoring Kinetics
When Equilibrium Lies Sometimes, numbers don’t add up. Unlock “Kinetics: Advanced Applications” Only in Terry’s Corner Why Terry’s Corner Most pharmacology pharmacology experience Whether you’re validating assays, refining kinetic models, or deciding which leads to advance
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Distinguish orthosteric vs. allosteric effects by extending predictions, not eyeballing plots—so you don’t advance
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
Adapted from Drescher H, Weiskirchen S, Weiskirchen R. Flow Cytometry: A Blessing and a Curse. Using Fluorescent Ligands Over Antibodies in Flow Cytometry Assays: Key Advantages These are key limitations Fluorescent ligands provide some key advantages that may solve these issues: 1. Using the advantages enumerated previously, fluorescent ligands provide new capabilities: - Principles of Advanced Flow Cytometry: A Practical Guide.
- Curve Shifts Don’t Lie, But Your Eyes Might
pharmacology experience Whether you’re validating assays, refining models, or deciding which leads to advance
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
While writing a literature review on opioid and alcohol addiction susceptibility, something shifted. drug combinations that mirror contamination patterns, and experimental designs that evolve with new adulterants She is especially interested in mu-opioid receptor signaling and how xylazine, as an alpha-2 adrenergic
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Breakthroughs this week: Decoding ADGRE5 signaling; Eli Lilly’s obesity pill vs Novo’s Wegovy; Certa Misinterpreting displacement curves in allosteric assays means discarding viable compounds—or worse, advancing GPCR Premium Membership Gives You an Edge The GPCR field is advancing at breakneck speed.
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Terry Kenakin's insights on target residence time can reshape how you evaluate and advance lead compounds fentanyl slows inhalation via opioid receptors, while xylazine prolongs exhalation through alpha-2 adrenergic Competitive Edge: Stay informed on emerging public health threats and the scientific research aimed at addressing Listen now to understand how two mechanisms intersect—and why pharmacologists are critical in addressing GPCR University Course Attendee Ready to gain a competitive advantage?
- Fluorescence Polarization in GPCR Research
Adapted from: Zhang Y, Tang H, Chen W, Zhang J. Optimizing GPCR Drug Discovery with Fluorescence Polarization: Key Advantages and Future Perspectives Advancing Fluorescence Polarization Assays with Custom Fluorescent Ligands Looking ahead, fluorescence expected to expand its role in GPCR research through the development of novel fluorescent probes and advanced Contact us to drive further advancements in GPCR drug discovery!
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
, Catherine Demery’s research is about receptors and signaling pathways—how mu-opioid and alpha-2 adrenergic The combination is not merely additive; it’s synergistic, shrinking tidal volume even when breathing With street-level contamination rising faster than medicine can adapt, Catherine’s work shows why overdose But that mechanism has no impact on xylazine, which works through alpha-2 adrenergic receptors. And the illicit supply is moving faster than clinical medicine can adjust.
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
organized by both the EFMC and the ACSMEDI, in an effort to share the most novel medicinal chemistry advancements She has a lot of experience working for bigger businesses which she now shares as an advisor for startups table discussion with these excellent scientists felt like a dream come true, and Maria enjoyed giving advice
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
It is involved in several pathophysiological processes such as Parkinson’s disease, depression, addiction homogeneous conditions, using lanthanide (europium, terbium) as donors.[17] Lanthanides provide unique advantages Specific binding is shown, obtained from total binding and unspecific binding ( a ) CB1R expressing adherent measurement (specific binding measured using CP55490 at 10 μM concentration) ( b ) CB2R expressing adherent Chem. 2019 , 62 (1), 276–287. https://doi.org/10.1021/acs.jmedchem.8b00368 . (9) Adams, A.
- Radioligands vs. Fluorescent Ligands: Binding Assays
Radioligands have been used to study GPCRs for decades, but with the advances in the fluorescence field They have several advantages, such as the minimal chemical modifications in the original ligand, high Representative images of non-fixed HCTT116 colorectal tumor cells co-stained with hA2B-A3 adenosine receptor Images were taken 2 min after the addition of Celt-327 to the medium. - Fluorescent probe
- Conjugation Strategies for Probe Development
and commonly used method is the amide coupling using acid and amine .[ 1 ] This method has several advantages only do they work in aqueous medium, but also in aprotic solvents like DMF, where you will need to add Its biggest advantage is the presence of Cys residues in proteins, although sometimes S-S bridge reduction
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
This iterative process of continuous, planned improvement ensures you're always addressing the next critical
- Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!
space to revisit core pharmacology concepts, master new ones, and sharpen your thinking to directly advance






























